An investigation on behalf of investors in Kadmon Holdings Inc (NYSE: KDMN) shares over potential wrongdoing at Kadmon Holdings Inc was announced.
San Diego, CA -- (SBWIRE) -- 10/31/2018 -- An investigation was announced for investors in shares of Kadmon Holdings Inc (NYSE: KDMN) concerning potential breaches of fiduciary duties by certain directors at Kadmon Holdings Inc.
Investors who purchased shares of Kadmon Holdings Inc (NYSE: KDMN) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Kadmon Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Kadmon Holdings Inc is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs
Kadmon Holdings Inc reported that its annual Total Revenue declined from $35.72 million in 2015 to $26.05 million in 2016 and that its Net Loss increased from $147.08 million to $208.75 million in 2016.
Shares of Kadmon Holdings Inc (NYSE: KDMN) declined from $10.23 per share in August 2016 to as low as $2.07 per share in August 2017.
Those who purchased shares of Kadmon Holdings Inc (NYSE: KDMN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels